​

GeneDx (WGS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

GeneDx Revenue Highlights

Latest Revenue (Y)

$305.45M

Latest Revenue (Q)

$76.87M

Main Segment (Y)

Diagnostic Test

Main Geography (Y)

Other

GeneDx Revenue by Period

GeneDx Revenue by Year

DateRevenueChange
2024-12-31$305.45M50.79%
2023-12-31$202.57M-13.69%
2022-12-31$234.69M10.60%
2021-12-31$212.19M18.33%
2020-12-31$179.32M-8.59%
2019-12-31$196.17M-

GeneDx generated $305.45M in revenue during NA 2024, up 50.79% compared to the previous quarter, and up 155.70% compared to the same period a year ago.

GeneDx Revenue by Quarter

DateRevenueChange
2024-09-30$76.87M9.02%
2024-06-30$70.51M12.96%
2024-03-31$62.42M8.72%
2023-12-31$57.42M7.72%
2023-09-30$53.30M9.44%
2023-06-30$48.71M12.90%
2023-03-31$43.14M-29.68%
2022-12-31$61.35M-26.29%
2022-09-30$83.23M130.13%
2022-06-30$36.17M-32.95%
2022-03-31$53.94M-6.68%
2021-12-31$57.80M33.87%
2021-09-30$43.18M-7.87%
2021-06-30$46.87M-27.00%
2021-03-31$64.20M0.38%
2020-12-31$63.96M65.66%
2020-09-30$38.61M-

GeneDx generated $76.87M in revenue during Q3 2024, up 9.02% compared to the previous quarter, and up 157.83% compared to the same period a year ago.

GeneDx Revenue Breakdown

GeneDx Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 22
Product and Service, Other$3.29M$7.36M
Diagnostic Test$302.16M$227.33M
Diagnostic Test, Third Party Insurance$234.70M-
Diagnostic Test, Institutional Customers$65.11M-
Diagnostic Test, Self Pay$2.34M-

GeneDx's latest annual revenue breakdown by segment (product or service), as of Dec 24: Diagnostic Test (49.73%), Diagnostic Test, Third Party Insurance (38.63%), Diagnostic Test, Institutional Customers (10.72%), Product and Service, Other (0.54%), and Diagnostic Test, Self Pay (0.39%).

Quarterly Revenue by Product

Product/ServiceDec 24Sep 24Jun 24
Product and Service, Other$2.76M$-544.00K$1.07M
Diagnostic Test$155.30M$77.42M$69.44M
Diagnostic Test, Institutional Customers$31.00M$17.41M$16.70M
Diagnostic Test, Self Pay$1.19M$460.00K$692.00K
Diagnostic Test, Third Party Insurance$123.10M$59.54M$52.05M

GeneDx's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Diagnostic Test (49.56%), Diagnostic Test, Third Party Insurance (39.28%), Diagnostic Test, Institutional Customers (9.89%), Product and Service, Other (0.88%), and Diagnostic Test, Self Pay (0.38%).

GeneDx Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 24
Other$3.16M

GeneDx's latest annual revenue breakdown by geography, as of Dec 24: Other (100.00%).

GeneDx Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
PRVAPrivia Health Group$1.74B$422.33M
CERTCertara$385.15M$94.82M
WGSGeneDx$305.45M$76.87M
HSTMHealthStream$291.65M$73.09M
DHDefinitive Healthcare$252.20M$62.70M
NRCNational Research$143.06M$35.82M
HCTIHealthcare Triangle$33.20M$2.41M
EUDAEUDA Health$3.71M$1.11M
ACONAclarion$45.72K$10.97K

WGS Revenue FAQ

What is GeneDx’s yearly revenue?

GeneDx's yearly revenue for 2024 was $305.45M, representing an increase of 50.79% compared to 2023. The company's yearly revenue for 2023 was $202.57M, representing a decrease of -13.69% compared to 2022. WGS's yearly revenue for 2022 was $234.69M, representing an increase of 10.60% compared to 2021.

What is GeneDx’s quarterly revenue?

GeneDx's quarterly revenue for Q3 2024 was $76.87M, a 9.02% increase from the previous quarter (Q2 2024), and a 44.22% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $70.51M, a 12.96% increase from the previous quarter (Q1 2024), and a 44.77% increase year-over-year (Q2 2023). WGS's quarterly revenue for Q1 2024 was $62.42M, a 8.72% increase from the previous quarter (Q4 2023), and a 44.70% increase year-over-year (Q1 2023).

What is GeneDx’s revenue growth rate?

GeneDx's revenue growth rate for the last 3 years (2022-2024) was 30.15%, and for the last 5 years (2020-2024) was 70.34%.

What are GeneDx’s revenue streams?

GeneDx's revenue streams in c 24 are Product and Service, Other, Diagnostic Test, Diagnostic Test, Third Party Insurance, Diagnostic Test, Institutional Customers, and Diagnostic Test, Self Pay. Product and Service, Other generated $3.29M in revenue, accounting 0.54% of the company's total revenue, down -55.26% year-over-year. Diagnostic Test generated $302.16M in revenue, accounting 49.73% of the company's total revenue, up 32.91% year-over-year. Diagnostic Test, Third Party Insurance generated $234.7M in revenue, accounting 38.63% of the company's total revenue Diagnostic Test, Institutional Customers generated $65.12M in revenue, accounting 10.72% of the company's total revenue Diagnostic Test, Self Pay generated $2.34M in revenue, accounting 0.39% of the company's total revenue

What is GeneDx’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of GeneDx was Diagnostic Test. This segment made a revenue of $302.16M, representing 49.73% of the company's total revenue.